WAM
BIIB icon

Wolverine Asset Management’s Biogen BIIB Stock Holding History

Wolverine Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5
Closed -$61K – 1239
2015
Q4 		$61K Hold
5
– – ﹤0.01% 1097
2015
Q3 		$56K Hold
5
– – ﹤0.01% 1247
2015
Q2 		$110K Hold
5
– – ﹤0.01% 1081
2015
Q1 		$120K Sell
5
-258
-98% -$102K ﹤0.01% 1013
2014
Q4 		$3.86M Hold
263
– – 0.08% 195
2014
Q3 		$3.67M Buy
263
+1
+0.4% +$330 0.08% 200
2014
Q2 		$3.3M Buy
262
+62
+31% +$18.7K 0.07% 201
2014
Q1 		$2.9M Sell
200
-35
-15% -$11.1K 0.06% 223
2013
Q4 		$2.86M Sell
235
-65
-22% -$16.8K 0.06% 264
2013
Q3 		$2.35M Hold
300
– – 0.05% 287
2013
Q2 		$1.8M Buy
+300
New +$64.1K 0.05% 331

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wolverine Asset Management's BIIB Position: Q3 2021 in Review

Wolverine Asset Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 568 shares — an estimated $196K sold.

Wolverine Asset Management first reported a position in BIIB in Q3 2013 and held it in 16 quarters. The position peaked at $1.91M in Q4 2013. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Wolverine Asset Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 568 Biogen shares in Q3 2021, an estimated $196K.
  • Wolverine Asset Management first reported a position in Biogen in Q3 2013 and held it in 16 quarters.
  • Wolverine Asset Management's Biogen position peaked at $1.91M in Q4 2013.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Wolverine Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.